Purpose Retinoblastoma is a youth cancer from the retina. proof efficacy for subconjunctival. R406. Maximal vitreal focus was 10-collapse less than the minimal focus required to destroy retinoblastoma cells (6). With this research, we centered on the SYK inhibitor R406. The orally obtainable prodrug of R406, fostamatinib (R788), offers advanced into late-phase medical trials for… Continue reading Purpose Retinoblastoma is a youth cancer from the retina. proof efficacy